Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Sarah Merritt
Lifestream Health Center, MD
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
148
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Feasibility and Impact of Adjunct Ketamine to Improve Methadone Treatment Outcomes for Patients with Opioid Use Disorder and Symptoms of Depression: A Pilot Trial Protocol
Number of pages: 30
Posted: 07 Feb 2023
Annabelle M. Belcher
,
Heather Fitzsimons
,
Aaron D. Greenblatt
,
Hannah Smith
,
Meghan Derenoncourt
,
Max Spaderna
,
Donald Gann Jr.
,
Mark Kvarta
,
Bethany DiPaula
, Sarah Merritt,
Ivana Mitic
,
Carlos Zarate
,
Todd Gould
,
Eric Weintraub
and
Sarah Kattakuzhy
- School of Medicine, - School of Medicine, - School of Medicine, - School of Medicine, - School of Medicine, - School of Medicine, - School of Medicine, - Maryland Psychiatric Research Center, - School of Pharmacy, Lifestream Health Center, MD, Baltimore Ketamine Clinic, Government of the United States of America - National Institute of Mental Health, - School of Medicine, - School of Medicine and - School of Medicine
Downloads
148
(508,926)
View PDF
Download
Abstract:
Medications for Opioid Use Disorder (MOUD), Depressive Symptoms, Methadone, Ketamine
Feedback